Related Experiment Videos
Molecular genetics of ABO
1Burnham Institute (La Jolla Cancer Research Center), CA 92037, USA. fyamamoto@burnham.org
Vox Sanguinis
|August 12, 2000
Summary
This year marks 100 years since the ABO blood group system discovery. Advances include understanding ABO genes, glycosyltransferases, and enabling ABO genotyping for transfusion medicine.
Area of Science:
- Immunology
- Genetics
- Transfusion Medicine
Background:
- The ABO blood group system, discovered 100 years ago, remains crucial for safe blood transfusion practices.
- Despite numerous blood group systems identified, ABO is paramount in transfusion medicine.
Purpose of the Study:
- To review the progress in understanding the molecular genetic basis of the ABO blood group system.
- To highlight advancements in ABO genotyping and enzyme engineering.
Main Methods:
- Elucidation of the molecular genetic basis of major ABO alleles.
- Identification of mutations affecting ABO glycosyltransferase activity and specificity.
- Development of ABO genotyping techniques.
Main Results:
- Understanding of ABO genes and the A and B glycosyltransferases has significantly advanced.
- Functional alleles and mutations impacting enzyme activity have been identified.
- ABO genotyping is now feasible, with potential for enzyme engineering.
Conclusions:
- The study underscores the significant progress in understanding the ABO blood group system's genetic and molecular basis.
- Current research is focused on understanding the functional significance of ABO gene polymorphism.
- These advancements are critical for the future of transfusion medicine and personalized therapeutics.